MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Roka Bioscience Company Profile (NASDAQ:ROKA)

Consensus Ratings for Roka Bioscience (NASDAQ:ROKA) (?)
Ratings Breakdown: 2 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.50 (162.24% upside)

Analysts' Ratings History for Roka Bioscience (NASDAQ:ROKA)
Show:
DateFirmActionRatingPrice TargetActions
3/6/2016Leerink SwannDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2015WedbushLower Price TargetNeutral$3.00 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015Bank of AmericaDowngradeNeutral -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2014Cowen and CompanyInitiated CoverageOutperform$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Roka Bioscience (NASDAQ:ROKA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/11/2016        
5/4/2016Q116($0.46)($0.47)$1.56 million$1.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2016Q415($0.48)($0.56)$1.66 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/11/2015Q315($0.53)($0.49)$1.75 million$1.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/13/2015Q215($0.51)($0.54)$1.58 million$1.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.50)($0.51)$1.44 million$1.51 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/26/2015Q414($0.52)($0.43)$1.44 million$1.36 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014($0.49)($0.64)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014Q214($11.28)$1.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Roka Bioscience (NASDAQ:ROKA)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.44)($0.44)($0.44)
Q2 20161($0.42)($0.42)($0.42)
Q3 20161($0.43)($0.43)($0.43)
Q4 20161($0.43)($0.43)($0.43)
(Data provided by Zacks Investment Research)
Dividend History for Roka Bioscience (NASDAQ:ROKA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Roka Bioscience (NASDAQ:ROKA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
11/17/2014David W J McgirrDirectorBuy50,000$3.60$180,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014Patrick J KerinsMajor ShareholderBuy383,333$12.00$4,599,996.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Roka Bioscience (NASDAQ:ROKA)
DateHeadline
06/28/16 06:04 PMROKA BIOSCIENCE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
06/27/16 03:16 PMROKA BIOSCIENCE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/17/16 02:56 PMRoka Bioscience, Inc. :ROKA-US: Earnings Analysis: Q1, 2016 By the Numbers -
03/15/16 01:58 PMCurrent Price Targets On Roka Bioscience, Inc. (ROKA) - Risers & Fallers - Current Price Targets On Roka Bioscience, Inc. (ROKA)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Roka Bioscience, Inc. (ROKA). The latest broker reports which are currently outstanding on Tuesday 15th of March state 0 analysts have a rating of “strong buy”, 0 analysts ...
03/09/16 03:13 PMROKA BIOSCIENCE, INC. Files SEC form 10-K, Annual Report -
03/07/16 05:26 AMRoka Bioscience downgraded by Leerink Partners -
03/04/16 03:05 PMRoka Bioscience Reports Fourth Quarter and Full Year 2015 Financial Results - [PR Newswire] - WARREN, N.J., March 4, 2016 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, ...
03/04/16 06:07 AMQ4 2015 Roka Bioscience Inc Earnings Release - After Market Close -
02/26/16 03:01 PMRoka Bioscience to Report Fourth Quarter and Full Year 2015 Financial Results on March 4, 2016 - [PR Newswire] - WARREN, N.J., Feb. 26, 2016 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA) , a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, ...
02/26/16 09:25 AMWhat Will Happen to Roka Bioscience Inc Next? The Stock Formed a Several Months Wedge Down - Business Standard Tribune - What Will Happen to Roka Bioscience Inc Next? The Stock Formed a Several Months Wedge DownBusiness Standard TribuneThe stock of Roka Bioscience Inc (ROKA) formed a down wedge with $0.63 target or 13.00% below today's $0.72 share price. The 6 months wedge indicates high risk for the $16.73M company. If the $0.63 price target is reached, the company will be worth ...
02/26/16 09:25 AMROKA BIOSCIENCE : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - 2015 ROKA BIOSCIENCE: Change in Directors or Principal Officers, Financial Statement.. 2015 ROKA BIOSCIENCE: MBio Diagnostics Announces a License and Development Partnersh.. 2015 ROKA BIOSCIENCE: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
02/25/16 04:21 PMROKA BIOSCIENCE, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand -
02/20/16 01:55 PMHow Many Roka Bioscience Inc (NASDAQ:ROKA)'s Analysts Are Bullish? - Clinton Financial - How Many Roka Bioscience Inc (NASDAQ:ROKA)'s Analysts Are Bullish?Clinton FinancialOut of 2 analysts covering Roka Bioscience (NASDAQ:ROKA), 0 rate it “Buy”, 0 “Sell”, while 0 “Hold”. This means NaN are positive. Roka Bioscience was the topic in 6 analyst reports since August 14, 2015 according to StockzIntelligence Inc. Below is a ...
02/20/16 01:55 PMRoka BioScience Inc. (ROKA) is Trading Lower on Unusual Volume for February 18 - Equities.com - Roka BioScience Inc. (ROKA) is Trading Lower on Unusual Volume for February 18Equities.comRoka BioScience Inc. (ROKA) experienced unusually high volume on Feb. 18, as the stock lost 0.74% to a closing price of $0.54. The stock saw 83,228 shares trade hands over the course of the day on 156 trades. Given that the stock's average daily volume ...
02/20/16 01:55 PMRoka BioScience Inc. (ROKA) is Trading Higher on Unusual Volume for February 19 - Equities.com - Roka BioScience Inc. (ROKA) is Trading Higher on Unusual Volume for February 19Equities.comRoka BioScience Inc. (ROKA) experienced unusually high volume on Feb. 19, as the stock gained 9.45% to a closing price of $0.58. The stock saw 130,576 shares trade hands over the course of the day on 178 trades. Given that the stock's average daily ...and more »
02/18/16 01:50 PMAnalyst Coverage Updates – Roka Bioscience, Inc. (ROKA) - Risers & Fallers - Analyst Coverage Updates – Roka Bioscience, Inc. (ROKA)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Roka Bioscience, Inc. (ROKA). The latest broker reports which are currently outstanding on Wednesday 17th of February state 1 analyst has a rating of “strong buy”, 0 ...Roka Bioscience Incorporated (NASDAQ:ROKA) Shorts Decreased by 20.98% After Short Coveringfdanewsalert.comall 2 news articles »
02/15/16 12:37 PMWhat's Propelling Roka Bioscience Inc to Decrease? The Stock Formed a Bearish Wedge Down - Sonoran Weekly Review - What's Propelling Roka Bioscience Inc to Decrease? The Stock Formed a Bearish Wedge DownSonoran Weekly ReviewThe stock of Roka Bioscience Inc (ROKA) formed a down wedge with $0.48 target or 12.00% below today's $0.54 share price. The 9 months wedge indicates high risk for the $9.37M company. If the $0.48 price target is reached, the company will be worth ...
02/10/16 03:14 PMROKA BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition -
02/10/16 01:05 PMMomentum Stock: Roka Bioscience Inc - CWRU Observer - Momentum Stock: Roka Bioscience IncCWRU ObserverRoka Bioscience Inc (NASDAQ:ROKA) is expected to report fourth quarter earnings on Thursday, Mar24. Roka Bioscience, Inc., a molecular diagnostics company, focuses on the development and commercialization of molecular assay technologies for the ...
02/08/16 12:32 PMLatest Analysts Reports On Roka Bioscience, Inc. (ROKA) - Risers & Fallers - Latest Analysts Reports On Roka Bioscience, Inc. (ROKA)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Roka Bioscience, Inc. (ROKA). The latest broker reports which have been released state 1 analyst has a rating of “buy”, 0 analysts “outperform”, 0 analysts “hold”, 1 ...
02/06/16 01:09 PMNicholas Valeriani Appointed to Roka Bioscience's Board of Directors - WARREN, N.J., Aug. 13, 2015 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today announced that Nicholas J. Valeriani has been ...
02/03/16 11:42 AMRoka Bioscience, Inc. (NASDAQ:ROKA): Quarterly Earnings Update - Investor Newswire - Roka Bioscience, Inc. (NASDAQ:ROKA): Quarterly Earnings UpdateInvestor NewswireAs per the research firms that were included in Zacks Research survey, Roka Bioscience, Inc. (NASDAQ:ROKA) is projected an EPS of $-0.46 for last quarter. The firm can release the earnings report on or around 2016-03-24. Since the ratings compiled by ...and more »
12/23/15 08:09 AMROKA BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit -
12/15/15 09:46 AMMBio Diagnostics Announces a License and Development Partnership With Roka Bioscience, Inc. - [Marketwired] - MBio Diagnostics, Inc., a company leading a new era in rapid, on-the-spot clinical diagnostics and sample testing, today announced a product development partnership and licensing agreement with Roka Bioscience, ...
12/08/15 12:17 PMROKA BIOSCIENCE, INC. Financials -
12/07/15 10:15 AMRoka Bioscience, Inc. Earnings Analysis: Q3, 2015 By the Numbers -
11/22/15 06:41 PMIs Identive Group, Inc. (INVE) A Good Stock To Buy? -
11/12/15 05:05 AMROKA BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Princ -
11/11/15 03:26 PMRoka Bioscience Reports Third Quarter 2015 Financial Results - [at noodls] - WARREN, N.J., Nov. 11, 2015 /PRNewswire / -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, ...
11/11/15 03:26 PMRoka Bioscience Announces CFO Transition - [at noodls] - WARREN, N.J., Nov. 11, 2015/PRNewswire / -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, ...
11/11/15 06:07 AMQ3 2015 Roka Bioscience Inc Earnings Release - After Market Close -
11/05/15 11:10 AMHologic Beats on Q4 Earnings, Revenues; FY16 View Strong -
About Roka Bioscience

Roka Bioscience logoRoka Bioscience, Inc. is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company has launched Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using: culture-based assays, immunochemical-based assays and molecular-based assays. The Company's Atlas instrument is a fully automated molecular diagnostic testing instrument designed to reduce labor costs and operator error in high-volume foodborne pathogen testing laboratories. The Atlas instrument is a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ROKA
  • CUSIP:
Key Metrics:
  • Previous Close: $0.57
  • 50 Day Moving Average: $0.656
  • 200 Day Moving Average: $0.771
  • P/E Ratio: N/A
  • P/E Growth: -0.040
  • Market Cap: $10.23M
  • Current Quarter EPS Consensus Estimate: $-2.000 EPS
Additional Links:
Roka Bioscience (NASDAQ:ROKA) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha